key: cord-0686351-vozhczf0
authors: Bels, Julia L.M.; van Kuijk, Sander M.J.; Ghossein-Doha, Chahinda; Tijssen, Fabian H.; van Gassel, Rob J.J.; Tas, Jeanette; Collaborators, MaastrICCht; Schnabel, Ronny M.; Aries, Marcel J.H.; van de Poll, Marcel C.G.; Bergmans, Dennis C.J.J.; Meex, Steven J.R.; van Mook, Walther N.K.A.; van der Horst, Iwan C.C.; van Bussel, Bas C.T.
title: Decreased serial scores of severe organ failure assessments are associated with survival in mechanically ventilated patients; the prospective Maastricht Intensive Care COVID cohort
date: 2020-11-17
journal: J Crit Care
DOI: 10.1016/j.jcrc.2020.11.006
sha: 7f11c8a8bbdf0391b4b0645e76cb4505246aaa01
doc_id: 686351
cord_uid: vozhczf0

BACKGROUND: The majority of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are admitted to the Intensive Care Unit (ICU) for mechanical ventilation. The role of multi-organ failure during ICU admission as driver for outcome remains to be investigated yet. DESIGN AND SETTING: Prospective cohort of mechanically ventilated critically ill with SARS-CoV-2 infection. PARTICIPANTS AND METHODS: 94 participants of the MaastrICCht cohort (21% women) had a median length of stay of 16 days (maximum of 77). After division into survivors (n = 59) and non-survivors (n = 35), we analysed 1555 serial SOFA scores using linear mixed-effects models. RESULTS: Survivors improved one SOFA score point more per 5 days (95% CI: 4–8) than non-survivors. Adjustment for age, sex, and chronic lung, renal and liver disease, body-mass index, diabetes mellitus, cardiovascular risk factors, and Acute Physiology and Chronic Health Evaluation II score did not change this result. This association was stronger for women than men (P-interaction = 0.043). CONCLUSIONS: The decrease in SOFA score associated with survival suggests multi-organ failure involvement during mechanical ventilation in patients with SARS-CoV-2. Surviving women appeared to improve faster than surviving men. Serial SOFA scores may unravel an unfavourable trajectory and guide decisions in mechanically ventilated patients with SARS-CoV-2.

Ethics approval and consent to participate:

The local institutional review board (Medisch Ethische Toetsingscomissie (METC) 2020-1565/ 300523) of the Maastricht UMC+ approved the study, which was performed based on the regulations of Helsinki. During the pandemic, the board of directors of Maastricht UMC+ adopted a policy to inform patients and ask their consent to use the collected data and stored left-over serum samples for COVID-19 research purposes. The study is registered in the Netherlands Trial Register (registration number NL8613).

Not applicable.

Availability of data and material:

No concrete agreements on data sharing have been made yet. Before any data is shared outside the MUMC+, a datasharing plan will be drawn up in consultation with the data officer that conforms to relevant laws and regulations concerning personal data.

The authors declare that they have no competing interests. 

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (also called is highly heterogeneous in its presentation. [1] [2] [3] Approximately 40% of patients are asymptomatic and 40% have mild illness, while around 20% require hospitalization, of whom 5-10% become critically ill requiring mechanical ventilation. [4] The current COVID-19 pandemic maximally stresses Intensive Care resources in many countries, as recently seen in the Netherlands. [5, 6] The SARS-CoV-2 disease course in mechanically ventilated patients is however largely unknown.

At first, SARS-CoV-2 infection appeared a severe respiratory infection only. [2] However, more recent data suggest that thrombosis, affecting the cardiovascular system, plays a significant additional role in complicating the disease course. [7, 8] Data on other organ system failures complicating the course of the disease are scarce. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Most likely, this multi-organ involvement occurs independent of comorbidities, as SARS-CoV-2 infection is an intercurrent disease, affecting the general population. [6] Progressive multi-organ disease increases mortality, although it may be heterogeneous over time and vary between and within individual patients. For example, data suggest that women are less severely affected by SARS-CoV-2 infection than men. [3, 14] The course of multi-organ disease could, therefore, also potentially differ between men and women. Furthermore, changes in the number and severity of organ systems involved over time may also include valuable prognostic information that may guide clinical decisions for mechanically ventilated patients.

The Sequential Organ Failure Assessment (SOFA) score, widely established to determine multi-organ failure in Intensive Care Unit (ICU) patients, is designed to evaluate changes in organ failure over time. [26] [27] [28] The SOFA score includes components reflective of the respiratory, coagulation, liver, cardiovascular, renal and central nervous systems. Whether trends in SOFA score during ICU admission are associated with outcome remains to be established for SARS-CoV-2 infection. [29] 

The manuscript was written following the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) guideline. [30] university teaching hospital in the southern part of the Netherlands. Usually, the Maastricht UMC+ ICU has 27 beds, divided over three subunits to which all types of critically ill patients are admitted.

During the COVID-19 pandemic, our ICU was rapidly stepwise upgraded to a maximum of 64 beds, consisting of six subunits with 52 beds for COVID-19 patients and two subunits with 12 beds for non-COVID Intensive Care patients. The study was designed to foster other datasets and registries according to the FAIR data principle in collaboration. [31] The local institutional review board (Medisch Ethische Toetsingscomissie (METC) 2020-1565/ 300523) of the Maastricht UMC+ approved the study, which was performed based on the regulations of Helsinki. During the pandemic, the board of directors of Maastricht UMC+ adopted a policy to inform patients and ask their consent to use the collected data and stored left-over serum samples for COVID-19 research purposes. The study is registered in the Netherlands Trial Register (registration number NL8613).

This study included all participants with respiratory insufficiency requiring mechanical ventilation and at least one PCR positive for SARS-CoV-2 and/or a chest CT scan strongly suggestive for SARS-CoV-2 infection, based on a CORADS-score of 4-5 scored by a radiologist. [32] Participants were followed until primary outcome was reached (i.e. either death in the ICU or discharged from the ICU). After training by qualified research staff and with daily supervision by a senior investigator, medical research interns and PhD candidates not involved in patient care included participants and collected clinical, physiological, and laboratory variables using a predefined study protocol (extensively described elsewhere). [31] For the present study, participants were included from March the 25 th , the inception of the cohort, until June the 23 rd 2020.

Within the MaastrICCht cohort every component of the SOFA score was collected daily in mechanically ventilated patients with a SARS-CoV-2 infection. [31] The SOFA score includes components reflecting the status of coagulation, the liver and the respiratory, cardiovascular, central nervous, and renal organ systems. Each organ system component is scored as one of five categories, ranging from 0 (normal organ function) to 4 (worst organ function). The SOFA score is the sum of the six organ system component scores and thus ranges from 0 to 24. The SOFA score was developed to evaluate multi-organ function daily, which is a major advantage to study the development of multiorgan failure over time. [26] Evidence for SARS-CoV-2 infection, and definition of SOFA score and its components are shown in Table 1 .

J o u r n a l P r e -p r o o f

The study population was divided into two subgroups, participants who had died during their ICU stay and participants who were discharged from the ICU alive.

Comorbidities were proposed as confounder as these can be associated with organ function at baseline and determine patient outcome. [33] For the present study, in addition to age and sex, chronic lung, liver and renal disease, and COVID-19 related comorbidities, such as obesity (body mass index, BMI kg/m 2 ), diabetes mellitus, and presence of cardiovascular risk factors, present on admission, were considered as potential confounders. Furthermore, we considered the admission Acute Physiology and Chronic Health Evaluation II (APACHE II) score as a potential confounder. The APACHE II score is a physiologically based classification system for measuring severity of illness in groups of critically ill patients. [34] APACHE II and SOFA score differ, although both score severity of critical illness. The APACHE II score was primarily developed to rank disease severity between patients over the first 24 hours of admission, whereas the SOFA score was developed to monitor disease severity within a patient over time. [26] 

The sample size was determined pragmatically; all participants eligible for the study that had been included in the cohort until June the 23 rd 2020 were included. The data were analysed with R version 3.6.1. The sample characteristics were described using mean and standard deviation (SD), median and interquartile range (IQR), or percentage, as appropriate.

First, the cohort was categorised into ICU-survivors and ICU-non-survivors. All participants reached a primary outcome. We computed estimates of group differences in the trajectory of average SOFA scores over time between those discharged alive, and those who had died. Next, we used linear mixed-effects regression with a random intercept and random slope with time to compute differences in average SOFA scores and differences in the slope over time between both groups. Specifically, we used unstructured variance-covariance matrix and an autoregressive correlation structure of the first order for longitudinal measures. To assess non-linear change over time, we added polynomials of time. Using the Akaike Information Criterion, the best fitting model for change over time was selected.

We computed the crude group differences (Model 1). Next, the model was adjusted for age and sex (Model 2), and additionally for COVID-19 related comorbidities such as obesity (BMI), diabetes mellitus, and the presence of cardiovascular risk factors and chronic lung disease, chronic J o u r n a l P r e -p r o o f Journal Pre-proof liver disease, and chronic renal disease at baseline (Model 3). Subsequently, model 3 was adjusted for the APACHE II score (Model 4), to further disentangle between patient disease severity (APACHE II) from within patient disease severity over time (SOFA score) in the association between disease severity and outcome. We also tested for effect-modification of the association between SOFA score over time and outcome by sex by adding a three-way interaction term to Model 2.

As twelve participants were transferred from ICU because of logistical reasons, we conducted a sensitivity analyses and repeated the main analyses without those 12. We checked the percentage of missing values for all potential confounding variables as determined in the previously published protocol. [31] Data would be imputed if the proportion of incomplete patients is over 5%, excluding the longitudinal measures as they were analysed using generalised linear mixed-effects regression. In case of over 5% of incomplete records, multiple imputation would be performed.

The MaastrICCht cohort includes a total of 94 participants at the time of data extraction. The mean age was 64.3±11.9 years, 21% were women. In total, 1555 serial SOFA scores had been recorded, with a mean of 7.7±2.3 on admission. The mean APACHE II score on admission was 15.8±5.7. Correlation coefficient between SOFA score and APACHE II score on admission was 0.54.

All participants reached primary outcome, one of which did not contribute any SOFA score. Of the 93 participants included in the analyses, 35 (38%) had died and 58 were discharged alive (supplemental Figure S1 ). The median duration of stay in the ICU was 16 days (1st and 3rd quartile: 8 and 24 days), with a maximum of 77 days. Table 2 shows the characteristics of the included participants stratified by primary outcome. Of all confounding variables, only BMI was missing in 1 (1%) participant. Hence, no data imputation was performed.

The mean SOFA score at baseline was 7.3 for eventual ICU-survivors (SD: 1.9) compared to 8.6 (SD: 2.8) for those who eventually died in the ICU (p-value for difference: 0.068). Figure 1 shows the individual trajectories of observed SOFA scores for ICU-survivors and ICU-non-survivors. Figure   2 shows the observed SOFA scores for ICU-survivors and ICU-non-survivors throughout follow-up, with lines superimposed showing the best-fitting overall trajectories over time, unadjusted for confounders. On average, ICU-survivors had a lower overall SOFA score during their ICU stay J o u r n a l P r e -p r o o f Adjustment for sex and age, and additionally for the presence of chronic lung disease, chronic liver disease and chronic renal disease, and obesity, diabetes mellitus, and cardiovascular risk factors, did not materially change the results (Table 3 ; Models 2 and 3). Additional adjustment for the APACHE II score reduced the negative regression coefficient that indicated the overall lower SOFA score over time (-0.99, 95% CI: -1.93; -0.06) for ICU-survivors compared to ICU-non-survivors, but the association remained significant. The improvement in SOFA score over time (-0.18, 95% CI: -0.25; -0.12) did not materially change (Table 3 , Model 4).

We observed a significant interaction between sex and the association between SOFA score over time and ICU mortality (p = 0.043). After adjustment for age, compared to non-survivors, women survivors had a lower overall SOFA score during their ICU stay (-1.76, 95% CI: -3.36; -0. 16 points, 95% CI: -0.08; -0.02), as compared to ICU-non-survivors. Bilirubin, the Glasgow coma score and thrombocytes count, indicators for respectively, the liver, the central nervous system, and coagulation components, showed no association with survival.

Sensitivity analyses excluding 12 patients transferred for logistical reasons did not alter any of the conclusions.

In this prospective cohort study including 93 mechanically ventilated participants with SARS-CoV-2 infection, we made five main observations. First, a decrease in SOFA score over time (which indicates improved organ function) is associated with ICU survival. Second, the association of the decrease in SOFA score with ICU survival remained present after adjustment for age, sex, the presence of chronic lung, renal and liver disease, obesity, diabetes mellitus, and cardiovascular risk factors, and after adjustment for the APACHE II score. Third, concerning the individual components J o u r n a l P r e -p r o o f Journal Pre-proof of the SOFA score; the respiratory, circulatory and renal organ components [35] appeared the most important drivers of the difference in trajectories of the SOFA score over time between ICU-survivors and ICU-non-survivors. The liver, the central nervous system and coagulation components did not seem to play a role [36, 37] . Fourth, the decrease in SOFA score over time between patients who survived the ICU vs. those that did not was statistically significantly greater for women (steeper slope) than men. Fifth, a higher admission SOFA score was not associated with ICU death.

Although previous studies report on SOFA score in COVID-19, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] 38] The APACHE II score was primarily developed to rank disease severity between patients over the first 24 hours of admission, whereas the SOFA score was developed to measure changes in disease severity over time. [40] The results show that in particular the difference in trajectories of SOFA score over time between ICU-survivors and ICU-non-survivors was independent of APACHE II score on admission. Furthermore, the SOFA score and APACHE II score on admission had a moderate correlation. Adjusting the association between SOFA score and outcome for APACHE II score appears odd as both scores identify disease severity of critical illness. This analysis, however, illustrates the fact that appropriate use of disease severity scores measuring alternative sources of variation (between patients vs. within patients) in multi-morbidity (i.e. both chronic multi-morbidity and acute multi-organ failure) is of utmost importance. The observation that trajectories of SOFA score are associated with outcome, independent of APACHE II score, could thus help to further refine the recent rapid guideline advice against the use of the SOFA score for ICU triage for patients with COVID-19. [41] The present results, for example, add that appropriate SOFA score application in critical care, aids to identify patients with a favourable disease course. [26, 42, 43] This cohort study design has several strengths. First, the study is prospective by design and allows for many serial measurements over time in patients with SARS-CoV-2 infection. Second, systematic data collection is performed using a predefined protocol. Third, sensitivity analyses did not Data are presented as mean (standard deviation) or count (percentage), unless indicated otherwise.

Differences were tested using the independent-samples t-test or Pearson's chi-square test, unless indicated otherwise. J o u r n a l P r e -p r o o f and time models the change over time for both groups separately)

The sample size for each of the analyses is reduced to 73 for the analyses for men and 20 for women.

J o u r n a l P r e -p r o o f A lower SOFA score indicates less organ dysfunction. Note that some jitter has been applied to the raw data to make multiple observations with the same values visible.

J o u r n a l P r e -p r o o f A lower SOFA score indicates less organ dysfunction.

Covid-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome

COVID-19: a novel coronavirus and a novel challenge for critical care

Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China

Epidemiology: Q&A: similarities and differences -COVID19 and influenza

Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations

Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Potential Effects of Coronaviruses on the Cardiovascular System: A Review

Critically ill SARS-CoV-2-infected patients are not stratified as sepsis by the qSOFA

Symptoms, course of illness and use of clinical scoring systems for the first 42 patients admitted to a Norwegian local hospital

Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1

Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan

Retrospective study of risk factors for severe SARS-Cov-2 infections in hospitalized adult patients

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19

The association of lung ultrasound images with COVID-19 infection in an emergency room cohort

ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. The Lancet

Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study

Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan

Clinical Characteristics of Coronavirus Disease 2019 in China

Comparison of CRB-65 and quick sepsis-related organ failure assessment for predicting the need for intensive respiratory or vasopressor support in patients with COVID-19

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine

Acute Physiology and Chronic Health Evaluation II Score as a Predictor of Hospital Mortality in Patients of Coronavirus Disease

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine

Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit

Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis

Sequential Organ Failure Assessment in H1N1 pandemic planning

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort (MaastrICCht)

Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak

Modern Epidemiology

APACHE-acute physiology and chronic health evaluation: a physiologically based classification system

Acute kidney injury in SARS-CoV-2 infected patients

Liver injury in critically ill patients with COVID-19: a case series

Longitudinal association between markers of liver injury and mortality in COVID-19 in China

Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study

Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan

Serial evaluation of the SOFA score to predict outcome in critically ill patients

Managing ICU surge during the COVID-19 crisis: Rapid Guidelines

Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study

Individualized prediction nomograms for disease progression in mild COVID-19

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal

The early change of SOFA score as a prognostic marker of 28-day sepsis mortality: analysis through a derivation and a validation cohort

We would like to thank all collaborators of MaastrICCht for their effort to support this study which is